Congenital Heart Defect: Clinical Trials

1 completed, 1 enrolling by invitation. 2 Phase 2, 2 Phase 3.

By phase and status

Phase	Trials	Status
Phase 2	2	Completed 1, Enrolling by invitation 1
Phase 3	2	Completed 1, Enrolling by invitation 1

Follow Congenital Heart Defect: new trials by email Literature Review of Congenital Heart Defect trials Research Report on Congenital Heart Defect

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
Nitric Oxide Effect on Brain and Kidney in Pediatric Patients Undergoing Cardiopulmonary Bypass Nitric Oxide (NO) 20 part per million (ppm), Standard of care cardiopulmonary bypass - Congenital Heart Disease, Congenital Heart Defect	Phase 2 / Phase 3	Enrolling by invitation	Vanderbilt University Medical Center	50	2022-04-25	2025-10-08
The Effects of Inhaled Nitric Oxide After Fontan Operation inhaled nitric oxide (iNO) - Congenital Heart Defect	Phase 2 / Phase 3	Completed	Ellen Spurrier	21	2008-02-01	2023-05-19

Narrower conditions

Heart Defects, Congenital (2)

Broader conditions

Cardiovascular Abnormalities (2)  ·  Cardiovascular Diseases (2)  ·  Congenital Abnormalities (2)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2)  ·  Heart Diseases (2)

Interventions

Endothelium-Dependent Relaxing Factors (1)  ·  Nitric Oxide (1)

Sponsors

Ellen Spurrier (1)  ·  Vanderbilt University Medical Center (1)

Countries

United States (2)

Top investigators

David P Bichell, MD (1)  ·  Ellen Spurrier, MD (1)